NCT04659031View on ClinicalTrials.gov

A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM)

PHASE1CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

January 10, 2025

Study Completion Date

January 10, 2025

Conditions

Inclusion Body Myositis

Interventions

DRUG

ABC008

ABC008

Trial Locations (4)

5000

Royal Adelaide Hospital, Adelaide

Unknown

Royal Brisbane, Herston

Perron Institute, Perth

Royal North Shore Hospital, Sydney

All Listed Sponsors

lead

Abcuro, Inc.

INDUSTRY